"Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that." ...

After permission to work from home was temporarily revoked in September, disabled CDC workers are still struggling to get needed accommodations, according to a letter sent to NIH Director and acting ...

Apple recently released new AirTags, and Presidents Day is bringing deals on the original model. Snag a four-pack of Apple ...

Tommaso Giacomel said he was struggling to breathe during his final ​​biathlon race at the 2026 Winter Olympics ...

Heart disease is the leading cause of death in the United States. Many patients with heart disease - including those suffering from atrial ...

TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025Treatment ...

In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 of treatment, with durable pain reduction and significant improvements in all key secondary ...

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...

Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally well tolerated BERKELEY HEIGHTS, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tonix ...

TORTOLA, British Virgin Islands, Feb. 25, 2026 /PRNewswire/ -- Cara Medical Ltd. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CARA System, a ...

BERLIN, Germany – BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world’s first CE-approved left bundle branch area pacing (LBBAP) high-voltage ...

The clinical management of patients with non-acute myocardial ischaemic syndrome (NAMIS) continues to evolve as increasingly effective treatment approaches become available. In this Review, Chiu et al ...